Elutia, Inc. - Class A Common Stock (ELUT)
2.7700
+0.2700 (10.80%)
NASDAQ · Last Trade: Apr 2nd, 9:03 PM EDT
Detailed Quote
Previous Close | 2.500 |
---|---|
Open | 2.520 |
Bid | 2.500 |
Ask | 3.100 |
Day's Range | 2.520 - 2.860 |
52 Week Range | 2.280 - 5.240 |
Volume | 14,053 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 48,634 |
About Elutia, Inc. - Class A Common Stock (ELUT)
Elutia, Inc. is a biotechnology company focused on developing and commercializing innovative therapies that aim to address unmet medical needs. The company specializes in regenerative medicine, particularly in the areas of tissue engineering and cell therapy, working to create advanced solutions that enhance the body's natural healing processes. Through rigorous research and development, Elutia is dedicated to transforming the treatment landscape for various conditions, improving patient outcomes, and contributing to the advancement of healthcare technologies. Read More
News & Press Releases

Company Announces Q3 Earnings and Conference Call Dates
Via ACCESSWIRE · October 17, 2024

ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 7, 2024

DALLAS, TX / ACCESSWIRE / July 17, 2024 / SWK Holdings Corporation (NASDAQ:SWKH) ("SWK" or the "Company"), a life science-focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided a corporate progress update as well as a summary of the achievements of its borrower portfolio companies.
Via ACCESSWIRE · July 17, 2024

Although growth stocks under $5 are inherently risky and unpredictable, their very nature also facilitates robust upside potential.
Via InvestorPlace · July 11, 2024

Via Benzinga · June 17, 2024

ELUT stock results show that Elutia missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 9, 2024

ELUT stock results show that Elutia missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024

Via Benzinga · October 4, 2023

Via Benzinga · September 25, 2023

Gainers MicroAlgo Inc. (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.
Via Benzinga · September 22, 2023

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via Benzinga · November 13, 2023

Via Benzinga · September 28, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.
Via Benzinga · September 21, 2023

Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to also serve as the company’s Chief Privacy Officer.
Via Benzinga · September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 104.5% to $0.1916.
Via Benzinga · September 20, 2023

Via Benzinga · September 20, 2023